Phase II trial of NP-001 in patients with amyotrophic lateral sclerosis

Trial Profile

Phase II trial of NP-001 in patients with amyotrophic lateral sclerosis

Planning
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2016

At a glance

  • Drugs NP-001 (Primary)
  • Indications Amyotrophic lateral sclerosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Apr 2016 According to a Neuraltus Pharmaceuticals media release, this trial is expected to initiated during the summer of 2016.
    • 04 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jun 2016, according to a Neuraltus Pharmaceuticals media release.
    • 02 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top